Tesamorelinacetat CAS:218949-48-5

Tesamorelin is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group.

Tesamorelin (formerly known as TH9507) is a synthetic growth hormone releasing factor that stimulates the pituitary gland in the brain to secrete growth hormone; This indirect approach seems to maintain more stable, natural levels, such as cjC-1295 DAC.Clinical trials have shown that sarmorine significantly reduces abdominal fat and has fewer side effects than human growth hormone itself,

Tesamorelin is a human growth hormone-releasing factor (GRF) analog. It works by stimulating the pituitary gland to release growth hormone (GH). This causes the breakdown of excess stomach fat.

Tesamorelin is made with growth hormone-releasing factor (GRF).Tesamorelin is used to reduce excess fat around the stomach that is caused by taking certain HIV medications. This condition is also called lipodystrophy (LYE-poe-DIS-troe-fee).Tesamorelin is not a weight-loss medication and should not be used to treat obesity.

Tesamorelin is the only FDA drug approved for the intended reduction of abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection. It stimulates the body's release of growth hormone, which is reduced in HIV lipodystrophy.

Tesamorelin is a stabilized analogue of the growth hormone-releasing factor (GRF) that induces growth hormone (GH) in a specific and physiological manner. To date, clinical studies suggest that Tesamorelin reduces visceral fat in HIV-infected patients with abdominal lipo-hypertrophy as well as reducing abdominal fat in all individuals studied.

you are allergic to any ingredient in tesamorelin or to mannitol
you are pregnant
you have cancer, an underactive pituitary gland, or a pituitary gland tumor
you have had your pituitary gland removed, pituitary gland surgery, radiation treatment of the head, or a head injury
Contact your doctor or health care provider right away if any of these apply to you.